Related references
Note: Only part of the references are listed.Harm related to recreational ketamine use and its relevance for the clinical use of ketamine. A systematic review and comparison study
Jan Van Amsterdam et al.
EXPERT OPINION ON DRUG SAFETY (2022)
Effect of Pretreatment of S-Ketamine On Postoperative Depression for Breast Cancer Patients
Peirong Liu et al.
JOURNAL OF INVESTIGATIVE SURGERY (2021)
Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial
Rebecca L. Rothberg et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
A qualitative and quantitative account of patient's experiences of ketamine and its antidepressant properties
Rachael L. Sumner et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Ecstasy (3,4-methylenedioxymethamphetamine): Cardiovascular effects and mechanisms
Diogo A. Fonseca et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Intravenous Ketamine as an Effective and Safe Treatment in a Suicidal Patient With Cancer Who Was Nil Per Os
Sany Rajagukguk et al.
PSYCHOSOMATICS (2020)
Associated factors of hope in cancer patients during treatment: A systematic literature review
Corine Baalen et al.
JOURNAL OF ADVANCED NURSING (2020)
The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review
David S. Mathai et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
Gabrielle Agin-Liebes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Ketamine as a mental health treatment: Are acute psychoactive effects associated with outcomes? A systematic review
Meryem Grabski et al.
BEHAVIOURAL BRAIN RESEARCH (2020)
A rapid positive influence of S-ketamine on the anxiety of patients in palliative care: a retrospective pilot study
Eduard Falk et al.
BMC PALLIATIVE CARE (2020)
Reviewing the Potential of Psychedelics for the Treatment of PTSD
Erwin Krediet et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments
Kyle T. Greenway et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2020)
Repeated subcutaneous esketamine administration for depressive symptoms and pain relief in a terminally ill cancer patient: A case report
Matheus Ghossain Barbosa et al.
PALLIATIVE MEDICINE (2020)
Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies
Joost J. Breeksema et al.
CNS DRUGS (2020)
MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study
Philip E. Wolfson et al.
SCIENTIFIC REPORTS (2020)
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study
Brian T. Anderson et al.
ECLINICALMEDICINE (2020)
Ketamine as augmentation for the treatment of major depression and suicidal risk in advanced cancer: Case report
Oscar Rodriguez-Mayoral et al.
PALLIATIVE & SUPPORTIVE CARE (2020)
Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials
Wei Zheng et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
The Efficacy of Ketamine in the Palliative Care Setting: A Comprehensive Review of the Literature
Nathaniel Goldman et al.
JOURNAL OF PALLIATIVE MEDICINE (2019)
Psychedelics for psychological and existential distress in palliative and cancer care
D. Rosenbaum et al.
CURRENT ONCOLOGY (2019)
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
Matthew W. Johnson et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy
Jennifer Dore et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2019)
Palliative Nursing and Sacred Medicine: A Holistic Stance on Entheogens, Healing, and Spiritual Care
William E. Rosa et al.
JOURNAL OF HOLISTIC NURSING (2019)
The Use of Methylphenidate for Physical and Psychological Symptoms in Cancer Patients: A Review
Beatrice Ng Andrew et al.
CURRENT DRUG TARGETS (2018)
Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders
Paul Glue et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study
E. Dakwar et al.
NEUROPHARMACOLOGY (2018)
Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review
Simon Reiche et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Effects of existential interventions on spiritual, psychological, and physical well-being in adult patients with cancer: Systematic review and meta-analysis of randomized controlled trials
Natalie Bauereiss et al.
PSYCHO-ONCOLOGY (2018)
Latent class analysis differentiation of adjustment disorder and demoralization, more severe depressive and anxiety disorders, and somatic symptoms in patients with cancer
I. Bobevski et al.
PSYCHO-ONCOLOGY (2018)
Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
Eduardo Ekman Schenberg
FRONTIERS IN PHARMACOLOGY (2018)
Case Report: Ketamine for Pain and Depression in Advanced Cancer
Jessica Sexton et al.
JOURNAL OF PALLIATIVE MEDICINE (2018)
Existential distress in cancer: Alleviating suffering from fundamental loss and change
Sigrun Vehling et al.
PSYCHO-ONCOLOGY (2018)
Risk Factors of Lower Urinary Tract Syndrome among Ketamine Users
I-Chun Chen et al.
LUTS-LOWER URINARY TRACT SYMPTOMS (2018)
Antidepressants for the treatment of depression in people with cancer
Giovanni Ostuzzi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress
Stephen Ross
INTERNATIONAL REVIEW OF PSYCHIATRY (2018)
Side-effects associated with ketamine use in depression: a systematic review
Brooke Short et al.
LANCET PSYCHIATRY (2018)
Ketamine rapidly relieves acute suicidal ideation in cancer patients: a randomized controlled clinical trial
Wei Fan et al.
ONCOTARGET (2017)
Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders
Paul Glue et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress
Thomas C. Swift et al.
JOURNAL OF HUMANISTIC PSYCHOLOGY (2017)
Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis
Alexander B. Belser et al.
JOURNAL OF HUMANISTIC PSYCHOLOGY (2017)
Low-Dose Ketamine in Chronic Critical Illness
Vivek K. Moitra et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2016)
Oral ketamine for the treatment of pain and treatment-resistant depression
Robert A. Schoevers et al.
BRITISH JOURNAL OF PSYCHIATRY (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
A longitudinal study on anxiety, depressive and adjustment disorder, suicide ideation and symptoms of emotional distress in patients with cancer undergoing radiotherapy
Manuel Hernandez Blazquez et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2016)
Mental disorders and the desire for death in patients receiving palliative care for cancer
Keith G. Wilson et al.
BMJ SUPPORTIVE & PALLIATIVE CARE (2016)
Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression
Bruno Romeo et al.
PSYCHIATRY RESEARCH (2015)
Ketamine for the Treatment of Depression in Patients Receiving Hospice Care: A Retrospective Medical Record Review of Thirty-One Cases
Alana Iglewicz et al.
PSYCHOSOMATICS (2015)
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
Peter Gasser et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Reevaluating the role of antidepressants in cancer-related depression: a systematic review and meta-analysis
Natalie Riblet et al.
GENERAL HOSPITAL PSYCHIATRY (2014)
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Peter Gasser et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2014)
Case Report: Long-Term Mood Response To Repeat Dose Intramuscular Ketamine in a Depressed Patient with Advanced Cancer
Claudia Grott Zanicotti et al.
JOURNAL OF PALLIATIVE MEDICINE (2013)
Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial
Scott A. Irwin et al.
JOURNAL OF PALLIATIVE MEDICINE (2013)
Co-morbid mental health conditions in cancer patients at working age - prevalence, risk profiles, and care uptake
S. Singer et al.
PSYCHO-ONCOLOGY (2013)
Mood and Pain Responses to Repeat Dose Intramuscular Ketamine in a Depressed Patient with Advanced Cancer
Claudia Grott Zanicotti et al.
JOURNAL OF PALLIATIVE MEDICINE (2012)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Existential Suffering in the Palliative Care Setting: An Integrated Literature Review
Patricia Boston et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2011)
Lower Urinary Tract Changes in Young Adults Using Ketamine
S. K. Mak et al.
JOURNAL OF UROLOGY (2011)
Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies
Alex J. Mitchell et al.
LANCET ONCOLOGY (2011)
Anxiety Disorders in Advanced Cancer Patients Correlates and Predictors of End-of-Life Outcomes
Ryan Spencer et al.
CANCER (2010)
Use of oral ketamine in chronic pain management: A review
Maren I. Blonk et al.
EUROPEAN JOURNAL OF PAIN (2010)
Oral Ketamine for the Rapid Treatment of Depression and Anxiety in Patients Receiving Hospice Care
Scott A. Irwin et al.
JOURNAL OF PALLIATIVE MEDICINE (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
The treatment of depression in patients with advanced cancer undergoing palliative care
Annabel Price et al.
Current Opinion in Supportive and Palliative Care (2009)
Intravenous Ketamine Burst for Refractory Depression in a Patient with Advanced Cancer
Lilianna Stefanczyk-Sapieha et al.
JOURNAL OF PALLIATIVE MEDICINE (2008)
Treatment of existential distress in life threatening illness: A review of manualized interventions
Katerine LeMay et al.
CLINICAL PSYCHOLOGY REVIEW (2008)
Suffering with advanced cancer
Keith G. Wilson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues
G Pelletier et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
Demoralization syndrome - a relevant psychiatric diagnosis for palliative care
DW Kissane et al.
JOURNAL OF PALLIATIVE CARE (2001)